Johanna Buchroithner

Author

Medical University of Vienna

Also Known As

A Olschowski, J Buchroithner, J. Buchroithner, Johanna Buchroithner

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna Medical University of Graz Kepler Universitätsklinikum Johannes Kepler University of Linz Voestalpine (Austria)

About

Johanna Buchroithner is an author at Medical University of Vienna specializing in glioma, medicine, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	560
2	Cell Biology	2	2	194
3	Molecular Biology	2	2	344
4	Engineering	1	1	39
5	Immunology	1	1	22

Johanna Buchroithner

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space Johanna Klughammer, Barbara Kiesel, Thomas Roetzer-Pejrimovsky, Nature Medicine Neuro-oncologyChromatinDna Methylation LandscapeGlioblastoma Disease ProgressionTumor Heterogeneity	2018	305
Inhibition of TGF- <i>β</i> 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies Peter Hau, Piotr Jachimczak, Reimar Schlingensiepen, Oligonucleotides	2007	217
FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities Sigrid Allerstorfer, Gudrun Sonvilla, Hendrik Fischer, Oncogene Oncogenic FactorHuman Glioblastoma MultiformeMedicinePathologyFibroblast Growth Factor	2008	105
Expression and Functional Activity of the ABC-transporter Proteins P-glycoprotein and Multidrug-resistance Protein 1 in Human Brain Tumor Cells and Astrocytes Sabine Spiegl‐Kreinecker, Johanna Buchroithner, Leonilla Elbling, Journal of Neuro-Oncology	2002	99
Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial Johanna Buchroithner, Friedrich Erhart, Josef Pichler, Cancers	2018	97
O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients Sabine Spiegl‐Kreinecker, Christine Pirker, Martin Filipits, Neuro-Oncology Epigenetic ChangePathologyTumor CellsTemozolomide TherapyHigh-grade Gliomas	2009	89
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07) Markus Hutterer, Martha Nowosielski, Johannes Haybaeck, Neuro-Oncology	2013	75
Overexpression of the human major vault protein in astrocytic brain tumor cells Walter Berger, Sabine Spiegl‐Kreinecker, Johanna Buchroithner, International Journal of Cancer	2001	63
Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables Friedrich Erhart, Johanna Buchroithner, René Reitermaier, Acta Neuropathologica Communications	2018	54
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space Johanna Klughammer, Barbara Kiesel, Thomas Roetzer, EngineeringEpigenetic ChangeGeneticsDna MethylationMolecular Biology	2017	39

Page 1